Press release
Global Idiopathic Pulmonary Fibrosis Market Size to Hit USD 6.16 billion by 2030, with 7.0% CAGR Growth
Idiopathic Pulmonary Fibrosis Market
The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ?
Increase in incidences of cancer worldwide, favorable reimbursement policies provided by manufacturers & insurance providers, and rise in cigarette smoking drive the growth of the global idiopathic pulmonary fibrosis market. However, the unavailability of the proper treatment options restrains the market growth. On the other hand, rise in number of pipeline drugs and untapped potential in developing countries present new opportunities in the coming years.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4407
๐๐จ๐ฉ ๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ
โข AstraZeneca PLC
โข Bristol-Myers Squibb Company
โข Boehringer Ingelheim
โข GNI Group Ltd
โข F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
โข Shiongi co Ltd
โข Mission Therapeutics
โข Biogen, Inc.
โข Galapagos NV
โข FibroGen, Inc.
๐๐๐ข๐จ๐ฉ๐๐ญ๐ก๐ข๐ ๐๐ฎ๐ฅ๐ฆ๐จ๐ง๐๐ซ๐ฒ ๐ ๐ข๐๐ซ๐จ๐ฌ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
Based on drug type, the pirfenidone segment accounted for the highest share in 2020, holding around three-fourths of the global idiopathic pulmonary fibrosis market, and is expected to continue its leadership status during the forecast period. Moreover, this segment is projected to manifest the highest CAGR of 7.2% from 2021 to 2030. This is due to rise in adoption of pirfenidone drugs such as Esbriet and Pirespa across the world. The research also analyzes the nintedanib segment.
Based on distribution channel, the retail pharmacies segment accounted for the highest share in 2020, contributing to nearly half of the global idiopathic pulmonary fibrosis market, and is estimated to continue its lead position during the forecast period. This is attributed to rapid increase in rate of idiopathic pulmonary fibrosis among the geriatric population, technological advancements, and lifestyle changes worldwide. However, the online providers segment is expected to portray the largest CAGR of 8.5% from 2021 to 2030. This is due to offers and discounts offered by providers and the availability of different types of drugs under a single platform.
Based on region, North America contributed to the highest market share in 2020, holding more than two-fifths of the global idiopathic pulmonary fibrosis market, and is projected to continue its lead in terms of revenue by 2030. This is attributed to high expenditure on R&D activities, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to manifest the fastest CAGR of 8.9% during the forecast period, owing to improvement in R&D facilities and rapidly developing economic conditions.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4407
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Idiopathic Pulmonary Fibrosis Market Size to Hit USD 6.16 billion by 2030, with 7.0% CAGR Growth here
News-ID: 3699416 • Views: โฆ
More Releases from Allied Market Research (AMR)
Fire Protection Coating Market Size, Growth Drivers and Revenue Outlook 2026-203 โฆ
According to a recent report published by Allied Market Research, titled "Fire Protection Coating Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Application: Global Opportunity Analysis and Industry Forecast, 2023-2032," the global fire protection coating market was valued at $4.4 billion in 2022 and is projected to reach $6.6 billion by 2032, registering a CAGR of 4.3% during the forecast period.
Download Sample Pages of Research Overview:โฆ
Waterproofing Membrane Market Size, Growth Momentum and Forecast 2024-2032 (CAGR โฆ
Allied Market Research has published a comprehensive report titled "Waterproofing Membrane Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2022-2032." According to the study, the global waterproofing membrane market was valued at $31.0 billion in 2022 and is projected to reach $51.5 billion by 2032, registering a CAGR of 5.4% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/1569
Market Growth Drivers and Challenges:
- The growth ofโฆ
Flexible Packaging Market Size, Explosive Growth Trends, and Forecast 2026-2032 โฆ
According to a recent report by Allied Market Research, the global flexible packaging market is projected to reach $325.8 billion by 2032, growing at a CAGR of 5.1% from 2023 to 2032. The market was valued at $197.4 billion in 2022, reflecting strong demand across food, personal care, pharmaceutical, and industrial applications.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/2028
What the Study Offers:-
The report provides a comprehensive quantitative and qualitative assessment ofโฆ
Boric Acid Market Size, Growth Trends and Forecast 2026-2032 (CAGR 5.6%)
Allied Market Research has published a comprehensive report titled "Boric Acid Market by Grade and End-Use Industry: Global Opportunity Analysis and Industry Forecast, 2022-2032." According to the study, the global boric acid market was valued at $1.0 billion in 2022 and is projected to reach $1.8 billion by 2032, growing at a CAGR of 5.6% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/1963
Key Growth Drivers:
The boric acid marketโฆ
More Releases for Idiopathic
Idiopathic Pulmonary Fibrosis Market Size & Share Analysis
The new report published by The Business Research Company, titled Idiopathic Pulmonary Fibrosis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the idiopathic pulmonary fibrosis market size has grown strongly in recent years. It will grow from $3.89โฆ
Charting New Frontiers: Idiopathic Gastroparesis Drugs Market Dynamics
The Idiopathic Gastroparesis Drugs Market ๐๐๐ฉ๐จ๐ซ๐ญ dissects the complex fragments of the Market in an easy-to-read manner. This report covers drivers, restraints, challenges, and threats in the Idiopathic Gastroparesis Drugs Market to understand the overall scope of the Market in a detailed yet concise manner.
Additionally, the Market report covers the top-winning strategies implemented by major industry players and technological advancements that steer the growth of the Market.
๐๐ฅ๐๐ข๐ฆ ๐ฒ๐จ๐ฎ๐ซ ๐๐จ๐ฉ๐ฒโฆ
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,โฆ
Idiopathic Membranous Nephropathy Treatment Market to Witness Significant Growth โฆ
Idiopathic membranous nephropathy a glomerular disease usually of abrupt onset and associated with the nephrotic syndrome. Membranous nephropathy occurs when the small blood vessels in the kidney (glomeruli), which filter wastes from the blood, become damaged and thickened. As a result, proteins leak from the damaged blood vessels into the urine (proteinuria).
R&D in idiopathic membranous nephropathy is expected to aid in growth of the idiopathic membranous nephropathy treatment market. Inโฆ
Global Idiopathic Scoliosis Treatment Market Size by Type (Infantile Idiopathic, โฆ
Global Idiopathic Scoliosis Treatmentโโโโโโโ Market Research report provides vital information related to the overall market and forecast from 2019 to 2026. This report includes the in-depth analysis of market size, share, growth, trends and regional demand and top layers the Idiopathic Scoliosis Treatmentโโโโโโโ Market. The major players dominating the market are focused upon throughout the by analyzing their revenue, their business summary, product segmentation along with the latest developments.
Get Sampleโฆ
Chronic Idiopathic Constipation Market Research Report 2024
Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipationโฆ
